Free Trial
NYSEAMERICAN:VTAK

Catheter Precision 5/6/2024 Earnings Report

Catheter Precision logo
$0.24 -0.01 (-2.32%)
Closing price 07/14/2025 04:10 PM Eastern
Extended Trading
$0.24 +0.00 (+0.42%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Catheter Precision EPS Results

Actual EPS
-$3.60
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Catheter Precision Revenue Results

Actual Revenue
$0.08 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Catheter Precision Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Catheter Precision's next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules.

Conference Call Resources

Catheter Precision Earnings Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Catheter Precision Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Catheter Precision? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Catheter Precision and other key companies, straight to your email.

About Catheter Precision

Catheter Precision (NYSEAMERICAN:VTAK) is a U.S.-based developer, manufacturer and marketer of over-the-wire and rapid exchange microcatheters, guide catheters and ancillary devices designed for diagnostic and interventional cardiology, peripheral vascular and neurovascular procedures. The company’s portfolio includes specialized, high–performance catheter products engineered to facilitate access to small or tortuous vessels, deliver therapeutic devices and contrast media, and enhance procedural efficiency and patient outcomes.

Since its founding in southern California in the early 1990s, Catheter Precision has invested in proprietary extrusion, braiding and molding technologies to produce catheters with consistent wall thickness, hydrophilic coatings and torque control. Over the years, the company has introduced incremental design innovations—such as atraumatic tapered tips and distal lumen markers—to meet evolving clinical requirements and to support a broad range of minimally invasive interventions.

Headquartered in San Clemente, California, Catheter Precision operates a U.S.-based manufacturing facility that adheres to rigorous quality and regulatory standards, including ISO 13485 certification and FDA registrations. The company’s products are distributed through a network of strategic partners and direct sales channels across North America, Europe, Asia Pacific and select emerging markets. Technical support teams work closely with physicians and catheterization laboratories to provide product training, case planning assistance and procedural troubleshooting.

Under the leadership of President and Chief Executive Officer Kevin Kremer, Catheter Precision continues to expand its product development pipeline and global footprint. The management team combines medical device experience with a focus on lean manufacturing, supply-chain resilience and ongoing collaboration with interventional specialists to address unmet clinical needs in cardiovascular and neurovascular care.

View Catheter Precision Profile

More Earnings Resources from MarketBeat